greeksoup/ stock research

U S Physical Therapy (USPH) FY2023 results: revenue $605 million, up 9.3% on the year

U S Physical Therapy Inc. (USPH) reported revenue of $605 million for fiscal 2023, the year ended 31 December 2023, up 9.3% on the year before. Net income was $28 million, down 12.2%, and diluted earnings per share $1.28. The figures are the company's own, from the 10-K it filed with the SEC on 29 February 2024.

Revenue
$605 million
+9.3% on the year
FY2016FY2023
Operating margin
8.4%
10.3% a year earlier
FY2016FY2023
Net income
$28 million
-12.2% on the year
FY2016FY2023
Diluted EPS
$1.28
-43.1% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue605553495+9.3%
Gross profit122112117+8.5%
Gross margin20.1%20.3%23.7%
Selling, general and administrative52.046.146.5+12.7%
Operating income50.556.870.6-11.1%
Operating margin8.4%10.3%14.3%
Pre-tax income49.455.673.2-11.1%
Income tax12.212.215.3-0.1%
Effective tax rate24.6%21.9%20.9%
Net income28.232.240.8-12.2%
Net margin4.7%5.8%8.2%
Diluted EPS$1.28$2.25$2.41-43.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow82.058.576.4+40.0%
Capital expenditure9.38.28.2+12.7%
Free cash flow72.750.368.2+44.5%
Free cash flow margin12.0%9.1%13.8%
Cash from investing-45.0-81.3-124
Cash from financing84.325.843.4+227.1%
Depreciation and amortisation15.714.711.6+6.5%
Share-based compensation7.27.37.9-0.4%
Buybacks0.0n/an/a
Dividends paid24.121.318.8+13.2%
Dividend per share$1.72$1.64$1.46+4.9%
Diluted shares, weighted14m13m13m+9.3%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity476316296+50.8%
Non-controlling interest1.21.31.6-3.5%
Redeemable equity175168155+4.4%
Debt147184118-20.1%
Operating lease liabilities76.777.974.2-1.6%
Other liabilities122112104+8.7%
Total liabilities and equity997858749+16.2%
Fixed assets26.124.723.0+5.5%
Goodwill510494435+3.1%
Intangible assets11010986.4+0.9%
Cash and equivalents15331.628.6+383.7%
Receivables51.951.946.3-0.1%
Other assets147147131+0.1%
Total assets997858749+16.2%

10-K for the year ended 31 December 2023, filed 29 February 2024: the filing.